19.05.2014 Views

IDEXX Laboratories, Inc. - PerkinElmer

IDEXX Laboratories, Inc. - PerkinElmer

IDEXX Laboratories, Inc. - PerkinElmer

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>.<br />

Antibody Assault: How CE Helped<br />

Uncover Processing Challenges<br />

Kristin Riley, Research Scientist<br />

Perkin Elmer Users Group Meeting<br />

6/7/12


2 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Reliable Science for Better Medicine<br />

• More than 350 scientists, engineers and veterinarians on staff<br />

worldwide<br />

• 50+ PhDs in biochemistry, cell biology, immunology, molecular<br />

biology, physical chemistry, physics and microbiology<br />

• 130+ specialists and 90+ board-certified veterinarians<br />

• Diverse technologies<br />

• Immunoassays<br />

• DNA probes<br />

• Clinical chemistries<br />

• Hematology<br />

• Molecular and cellular biology<br />

3 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


<strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>.<br />

2011 Revenue: $1.219 billion<br />

4 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Companion Animal Group<br />

Diagnostics and information technology solutions; 2011 Revenue: $1.0 billion<br />

5 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Rapid Assays: Point-of-care SNAP ® kits<br />

Market leader: Canine • Feline • Equine<br />

• Family of proprietary SNAP ® tests<br />

• SNAP ® 4Dx ® Plus Test,<br />

launched in April, detects<br />

six vector- and tick-borne<br />

diseases in one SNAP kit<br />

• Client value with pet-owner<br />

reporting<br />

6 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


7 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Rare Reagent tPilot tPlant tCOE<br />

• <strong>Inc</strong>orporate Cycles of Learning on Process Development and Product<br />

Support<br />

• Mitigate risk earlier in the product development lifecycle<br />

• Apply rational design and structure/functional relationships to<br />

reagents<br />

8 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


What do we do?<br />

• Scale up and transfer robust processes for reagent<br />

manufacture<br />

• Analytical Characterization<br />

mAU<br />

15.49<br />

30.0<br />

12.96<br />

25.0<br />

HRPO <strong>Inc</strong>orporation Ratio = 0.72<br />

20.0<br />

15.0<br />

10.0<br />

11.18<br />

11.11 15.51<br />

5.0<br />

15.49<br />

0.0<br />

9 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.<br />

0.0 5.0 10.0 15.0 20.0 25.0 ml


The Tool Box<br />

•Process Scale up:<br />

• Sciclone G3 (use with PhyNexus tips)<br />

• Chromatography<br />

• Particle Coating<br />

• Conjugations<br />

• Purifications<br />

10 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


The Tool Box<br />

• Analytical Characterization:<br />

• SEC/MALS<br />

• CE<br />

• LC/MS<br />

• RP-HPLC<br />

• DLS<br />

• FT-IR<br />

• TGA<br />

• Outsourced: NMR, OR, Elemental analysis, 2D gels etc.<br />

11 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Antibody-Enzyme Bioconjugates for<br />

Immunoassays<br />

ENZ<br />

NH 2<br />

ENZ<br />

H<br />

N<br />

O<br />

O<br />

N<br />

O<br />

HS<br />

SH<br />

O<br />

O<br />

O<br />

N<br />

O<br />

O<br />

N<br />

O<br />

ENZ<br />

H<br />

N<br />

O<br />

O<br />

N<br />

O<br />

S<br />

Sulfo-SMCC<br />

12 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


• IgYs are ~180 kD.<br />

IgY Antibodies<br />

• There are many (>>10) disulfide bonds inter and intra chain(s) in an IgY.<br />

• The MW differential (relative to an IgG) is in the heavy chain (Fc)<br />

IgG<br />

IgY<br />

13 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.<br />

Wilmar Dias da Silva, Denise V. Tambourgi. Veterinary Immunology and<br />

Immunopathology 135 (2010) 173–180.


Process Map for Conjugation<br />

Activate Enzyme<br />

Thaw and<br />

Reduce Antibody<br />

Purify Ab from<br />

Reductant<br />

<strong>Inc</strong>ubate with<br />

Enzyme<br />

Analytical<br />

Analysis<br />

Storage for use<br />

in Product<br />

14 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Characterization by Analytical SEC<br />

mAU<br />

Conj 40.0<br />

( 30.00<br />

20.0<br />

(A280)<br />

Conj (A403)<br />

Ab (A280)<br />

ENZ (A280)<br />

ENZ (A403)<br />

• Advantage:<br />

• Use “ENZ incorporation<br />

ratio” (Area 403 / Area 280)<br />

to provide spec for<br />

predictive success of<br />

conjugate.<br />

10.0<br />

• Disadvantage:<br />

• Method resolution is<br />

not optimal for individual<br />

species. (Limited by<br />

column choice)<br />

0.0<br />

0.0 5.0 10.0 15.0 20.0 25.0 ml<br />

15 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Characterization by Analytical SEC<br />

mAU<br />

200<br />

Non-Reduced Ab<br />

150<br />

shown in orange<br />

Reduced Ab<br />

shown in green<br />

100<br />

50<br />

0<br />

0.0 5.0 10.0 15.0 20.0 25.0 ml<br />

16 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Non-Reduced IgY Ab (in non-reducing CE conditions)<br />

Intact Ab<br />

System<br />

Peak<br />

Reduced IgY Ab (in non-reducing CE conditions)<br />

Light<br />

Chain<br />

Heavy<br />

Chain<br />

?<br />

17 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Characterization by Analytical CE<br />

Overlay: Non-Reduced and Reduced Ab<br />

Blue=Non-<br />

Reduced Ab<br />

Red=Reduced<br />

Ab<br />

18 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Enzyme in non-reducing conditions<br />

ENZ<br />

Conjugate in non-reducing conditions<br />

19 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Conjugate and Components by CE<br />

Conclusions<br />

• We have limited or no selectivity in disulfide reduction. Most of the IgY S-S is broken by<br />

the reduction.<br />

• We are relying on hydrophobic, H-bond and ionic interactions to maintain IgY structural<br />

integrity.<br />

• Of the 7 ENZ containing IgY conjugate species in CE only four contain active light chain.<br />

• Free, unconjugated light chain is a significant fraction<br />

• Conjugated heavy-chain-only species are a significant fraction<br />

20 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


The Rescue<br />

• Metal ions have been shown to catalyze disulfide formation by oxidation of thiols<br />

21 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Process Map for Conjugation<br />

• Metal ions were added to final conjugate to oxidize disulfides and stabilize Ab<br />

Activate Enzyme<br />

Thaw and<br />

Reduce Antibody<br />

Metal Ions added,<br />

ON incubation<br />

Purify Ab from<br />

Reductant<br />

<strong>Inc</strong>ubate with<br />

Enzyme<br />

Analytical<br />

Analysis<br />

22 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.<br />

Storage for use<br />

in Product


Non-Reduced IgY Ab (in non-reducing CE conditions)<br />

Reduced IgY Ab (in non-reducing CE conditions)<br />

Light<br />

Chain<br />

23 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Control Conjugate<br />

Free ENZ<br />

Conjugate<br />

Species<br />

Free Light Chain<br />

Conjugate in presence of 5X Cu(II) ions<br />

24 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Control Conjugate<br />

Conjugate in presence of non-catalyzing M+ ion<br />

25 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


<strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>.<br />

Global l leader<br />

• A portfolio of businesses with<br />

global market leadership<br />

• Pet healthcare technology<br />

• Production animal diagnostics<br />

• Water microbiology<br />

• Strategy of innovation in diagnostic<br />

and information technology<br />

• Track record of growth and<br />

profitability<br />

26 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Next tSteps<br />

• Functional Analysis<br />

• Study other conjugates<br />

• Glycan analysis<br />

27 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.


Thank you!<br />

Extended Team Members:<br />

Kaitlin Lawlor<br />

Chris Stetson<br />

Rudy Groat<br />

Julie Cross<br />

28 | © 2012 <strong>IDEXX</strong> <strong>Laboratories</strong>, <strong>Inc</strong>. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!